Physiological hyperglycemia has been speculated to alter phosphoinositide (PPI; inositol phospholipid) signal transduction in cells prone to diabetic complications by two separate mass-action mechanisms with antiparallel putative effects on diacylglycerol (DAG): (i) sorbitol-induced depletion of myo-inositol leads to diminished PPI synthesis and turnover and DAG release, and (it) elevated glucose-derived DAG precursors enhance de novo DAG synthesis. Because the first mechanism is mediated by aldose reductase (AR2), which converts glucose to sorbitol, the effects of glucose on basal and stimulated PPI signaling were explored in lines of cultured human retinal pigment epithelial cells differing widely in their basal AR2 gene expression and enzymatic activity. The results suggest that the effects of glucose on PPI signaling vary inversely with the level of AR2 activity and parallel the extent of AR2-induced myo-inositol depletion.
DAG precursors enhance de novo DAG synthesis. Because the first mechanism is mediated by aldose reductase (AR2), which converts glucose to sorbitol, the effects of glucose on basal and stimulated PPI signaling were explored in lines of cultured human retinal pigment epithelial cells differing widely in their basal AR2 gene expression and enzymatic activity. The results suggest that the effects of glucose on PPI signaling vary inversely with the level of AR2 activity and parallel the extent of AR2-induced myo-inositol depletion.
The hyperglycemia of diabetes has been speculated to alter phosphoinositide (PPI; inositol phospholipid) signal transduction, especially basal and agonist-stimulated intracellular diacylglycerol (DAG) mass, in cells prone to diabetic complications by one oftwo mechanisms. In the first, exemplified by peripheral nerve in experimental diabetes, glucoseinduced aldose reductase (AR2)-mediated sorbitol accumulation induces reciprocal depletion of myo-inositol (MI) , such that it becomes rate-limiting for critical components of PPI synthesis and arachidonoyl-DAG production that regulate Na+, K+-ATPase activity, leading to slow nerve conduction (1) (2) (3) . This biochemical response pattern to glucose has been modeled in cultured human retinal pigment epithelial (RPE) cells (2, 4) expressing aberrantly high levels of the AR2 gene (5) and enzyme (6) , which is responsible for conversion of glucose to sorbitol. However, the detailed interaction between glucose-induced MI depletion and inhibition of the phosphatidylinositol (PI) synthase reaction, for which MI and CDPdiglyceride (CDP-DG) function as cosubstrates, remains controversial (1, 7) . Several independent lines of investigation suggest that this interaction may be quite complex, involving functionally discrete metabolic pools of MI, PPI, and/or PI synthase (1) (2) (3) . In the second metabolic response pattern to glucose, exhibited in vitro by retinal endothelial and glomerular cells with relatively low AR2 activity (1, 8, 9) , DAG content, glucose incorporation into DAG, and protein kinase C translocation from the cytosolic to the membrane fraction are all increased after exposure to hyperglycemic concentrations of glucose (10) (11) (12) . This 
pattern has been
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. ascribed to enhanced de novo DAG synthesis from glucosederived precursors such as a-glycerophosphate and phosphatidic acid consequent to (13) or independent of (10-12) sorbitol pathway activation by glucose. This enhanced DAG synthesis has been speculated to exaggerate microvascular responses to growth factors and vasodilators in diabetes (10) (11) (12) (13) . The role of AR2 expression in determining which of these two response patterns to glucose predominates was explored in RPE cells, including a recently reported RPE cell line that constitutively overexpresses AR2 mRNA and enzyme (5, 6).
MATERIALS AND METHODS
Cell Culture. The Michigan Eye Bank supplied human postmortem eyes from which primary RPE cell lines were established as described (4) . Experiments were performed on passage numbers 10-18 of RPE cell lines established from three separate patients (RPE 91, RPE 125, and RPE 45). RPE 91 constitutively overexpresses AR2 mRNA and enzyme (5, 6) and exhibits exaggerated sorbitol accumulation, MI depletion, and PI synthase inhibition when exposed to 20 mM glucose (2, 5, 6) . Cells were cultured and exposed to experimental conditions for 7 days as described (2, 5, 6, 14 (Fig. 1) . In RPE 91 exposed to 20 mM glucose, ARI (10 ,uM sorbinil) decreased sorbitol to undetectable levels and reversed the reduction in MI. Sorbinil had no effect on MI in RPE 125 and RPE 45 ( 
1) (6).
Effect of Glucose and ARI on Basal and Stimulated PI Synthase in High and Low AR2 RPE Cells. In 5 mM glucose, a maximally stimulating concentration of carbachol (14) produced no significant change in [3H]CDP-DG in RPE 91 cells ( Fig. 2A) , despite a 2-to 3-fold increase in 32p incorporation into PI (Fig. 3) . These findings are consistent with an increased rate of resynthesis of PI following carbacholstimulated PPI hydrolysis (14) with either PPI-derived CDP-DG rather than MI being the rate-limiting substrate or carbachol coordinately stimulating phospholipase C and PI synthase. Conditioning RPE 91 in 20 mM glucose for 7 days (337% ± 16% vs. 317% ± 15%; P, not significant), despite identical reduction in both basal and stimulated incorporation in the latter condition. These observations are consistent with the hypothesis that carbachol-stimulated PI synthesis may partly bypass or reverse the inhibition of the PI synthase reaction caused by MI depletion. In contrast to RPE 91, RPE 45 exhibited no consistent alteration after 20 mM glucose exposure for 7 days in basal [3H]CDP-DG (Fig. 2B ) or in carbachol stimulation of 32p incorporation into PI, phosphatidylinositol 4-phosphate, or phosphatidylinositol 4,5-bisphosphate (respectively, 303% ± 27%, 111% ± 9%, and 103% ± 10% in 5 mM glucose vs. 324% ± 47%, 154% ± 10%, and 132% ± 14% in 20 mM glucose; P not significant glucose exposure (1.47 ± 0.09 pmol/nmol of phosphate in 5 mM glucose and 1.44 ± 0.11 pmol/nmol of phosphate in 20 mM glucose; n = 3; P not significant). Because these enzymatic mass analyses detect all DGs, including but not limited to DAG, and because the molecular species of DAG derived de novo from glucose differ from those released by PPI hydrolysis (17) , the distribution and concentration of individual DAG molecular species (16) were determined in unstimulated and carbachol-stimulated high AR2 RPE 91 and low AR2 RPE 45 in 5 or 20 mM glucose for 7 days. The total DAG levels (sum of the separated species) were marginally lower in RPE 91 vs. RPE 45 under unstimulated conditions in 5 mM glucose: 156.3 ± 29.3 (n 2 6) vs. 230.4 ± 41.4 (n = 3) pmol/mg of protein (P not significant). The 18:0-20:4 species (Fig. 6A) , which has been previously shown to be the major DAG species released by PPI hydrolysis (18), coeluted with 16:0-20:3-DAG (16) and together constituted =2% of total DAG in both cell lines. Trivial differences in the distributions of other molecular species were seen between the two cell lines (data not shown).
Exposure of RPE 91 to 20 mM glucose for 7 days marginally lowered total DAG, but several DAG species including those most likely derived from PPI turnover (e.g., 18:0-20:4 and 16:0-20:3) were reduced by 20-30% (Fig. 6A, bars 1 and  4) . Some DAG species were unaffected, whereas the composite peak containing 18:0-18:1 and 16:0-20:1 was significantly increased 19% (data not shown), indicating distinct compartmentalization of DAG pools under hyperglycemic conditions, consistent with a dual effect of glucose to specifically diminish PPI-derived DAG while increasing other DAG species possibly by de novo synthesis from glucose (11) (12) (13) . In RPE 45, 20 mM glucose significantly increased total DAG (Fig. 6B, bar 1 (Fig. 6A, bars 2 and 3) . In RPE 45, the 47% higher basal total DAG level increased only (Fig. 6A , bars 2 and 3 and bars and 6), as well as for all other DAG groups (data not shown). Accordingly, the absolute DAG levels attained by these species were also lower after carbachol stimulation in proportion to their lower basal levels (data not shown). Thus, exposure of high AR2 RPE cells to 20 mM glucose reduced the levels of the more unsaturated DAG molecular species (presumably derived from PPI) to a similar degree in both the basal and carbachol-stimulated state, paralleling the effects of 20 mM glucose on PI synthesis and PPI turnover. In low AR2 RPE 45, 20 mM glucose marginally increased total but not 18:0-20:4-and 16:0-20:3-DAG (Fig. 6B, bars 1 and 4) in the basal state without significantly affecting the percent stimulation or maximal levels after carbachol of any DAG molecular species (Fig. 6B, bars 2 and 3 and bars 5 and 6 (5, 6) , although the rise in enzymatic activity is delayed (6) . As anticipated by the compatible osmolyte hypothesis of Burg, and as recently reported (6) (11) (12) (13) 17 Thus glucose impairs basal as well as stimulated accumulation of PPI-derived DAG in high AR2 cells through polyol u i pathway activation, MI depletion, PI synthase inhibition, and lowered basal and stimulated PPI turnover (1) . The lack of exaggerated glucose-induced CDP-DG accumulation and PI synthase inhibition after carbachol stimulation suggests that either agonist-induced phospholipase C activation preferentially hydrolyzes glucose-insensitive (or less glucose sensitive) PPI pools or that M3 muscarinic agonists coordinately increase both phospholipase C and PI synthase activities, the latter either directly or via compartmentalized release of MI from PPI.
This persistent defect in PPI turnover and distribution of DAG molecular species after carbachol stimulation exemplifies impaired PPI-mediated signal transduction in glucoseexposed, MI-depleted RPE cells with high AR2 activity. A similar biochemical pattern has been described in sciatic nerve from the streptozotocin-induced diabetic rat, where carbachol-stitnulated PPI turnover and arachidonoyl-DAG are reduced (3), and in cultured calf retinal pericytes, where endothelin 1-induced DAG accumulation and protein kinase C activation are blunted after glucose exposure (12) . Thus, RPE 91 may appropriately model cells with high AR2 activity that are susceptible to diabetic complications. Whether other PPI-dependent signal transduction pathways such as intracellular calcium mobilization or PI-3-kinase are also affected by glucose-induced MI depletion in such cells with high AR2 activity remains to be explored in RPE 91 and other appropriate models.
These observations argue strongly that the directionality of glucose-induced perturbation of basal and stimulated PPI metabolism reflects AR2 expression and AR2-dependent MI depletion rather than other intrinsic characteristics of high and low AR2 cell lines. According to this construct, the degree of AR2 expression and/or activity would determine which of the two most frequently cited effects of glucose on PPI-or DAG-mediated signal transduction predominates: AR2-mediated MI depletion, PI synthase inhibition, and reduced arachidonyl-DAG (1, 3) on one hand; or a more generalized increase in de novo DAG synthesis by AR2-independent or AR2-dependent mechanisms on the other (11, 12, 19) . [In vitro studies suggest that protein kinase C is activated equally by DAG species with various saturated or unsaturated fatty acyl chains (20) . However in vivo data suggest that DAGs derived from different membrane lipids and/or various protein kinase C subspecies may be highly compartmentalized intracellularly (21) .] Thus disparate effects of glucose on DAG in high and low AR2 conditions may have quantitatively and/or qualitatively distinct implications for DAG-mediated signaling (21) .
The intriguing possibility that glucose could have opposite effects on DAG in cells with high or low AR2 activity warrants further investigation, especially in view of the cell-specific localization of AR2 in cellularly heterogeneous tissues that exhibit diabetic complications (1, 7, 8) . Discordant effects of glucose on DAG levels and molecular species in retinal pericytes (11) and endothelial cells (9) could produce simultaneous but diametrically opposite or at least divergent (21) effects on growth factor responsiveness and the cell cycle, promoting the simultaneous pericyte loss and endothelial cell replication characteristic of early diabetic retinopathy. Similarly, AR2-related reductions in arachidonoyl-DAG and related molecular species in diabetic nerve could also explain some of the reported beneficial effects of dietary essential fatty acid supplementation (22, 23) or prostaglandin analogs (24) on nerve function in the streptozotocin-induced diabetic rat. Variations in AR2 gene expression or activity over time and between species producing antiparallel effects on MI and DAG could also partially address the so-called "myo-inositol paradox" as described by Matschinsky and coworkers (7) . Finally, ARI treatment may theoretically convert the biochemical response to hyperglycemia from a pattern of reduced PPI-derived DAG to one of increased DAG synthesis in a tissue-specific manner depending upon intrinsic level AR2 activity, the degree of AR2 inhibition, and the capacity for de novo synthesis of PPI precursors from glucose.
